IntroductionSelf-testing for COVID-19 (C19ST) based on antigen detecting diagnostics could significantly support controlling the SARS-CoV-2 pandemic. To inform the World Health Organization in developing a C19ST guideline, we performed a systematic review and meta-analysis of the available literature.MethodsWe electronically searched Medline and the Web of Science core collection, performed secondary reference screening, and contacted experts for further relevant publications. Any study published between December 1, 2020 and November 30, 2021 assessing the epidemiological impact and clinical utility of C19ST was included. Study quality was evaluated using the Newcastle Ottawa Scale (NOS). The review was registered on PROSPERO (CRD42022299977).Results11 studies only from high-income countries with an overall low quality (median of 3/9 stars on the NOS) were found. Pooled C19ST positivity was 0.2% (95% CI 0.1% to 0.4%; eight data sets) in populations where otherwise no dedicated testing would have occurred. The impact of self-testing on virus transmission was uncertain. Positive test results mainly resulted in people having to isolate without further confirmation of results (eight data sets). When testing was voluntary by study design, pooled testing uptake was 53.2% (95% CI 36.7% to 68.9%; five data sets. Outside direct health impacts, C19ST reduced quarantine duration and absenteeism from work, and made study participants feel safer. Study participants favored self-testing and were confident that they performed testing and sampling correctly.ConclusionsThe present data suggests that C19ST could be a valuable tool in reducing the spread of COVID-19, as it can achieve good uptake, may identify additional cases, and was generally perceived as positive by study participants. However, data was very limited and heterogenous, and further research especially in low- and middle-income countries is needed to assess the clinical utility and epidemiological impact of C19ST in more detail.CONTRIBUTIONS TO THE LITERATURE- COVID-19 self-testing (C19ST) using antigen detection could conceivably support pandemic control. A current PubMed search found no systematic evidence synthesis of studies assessing the epidemiological impact and clinical utility of C19ST implementation- We systematically reviewed and meta-analyzed 11 studies including more than 1.1 million persons tested- C19ST can achieve good uptake, may identify additional cases, and was general perceived as positive by study participants, suggesting it to be a valuable tool in reducing the spread of SARS-CoV-2- Further data especially from low- and middle-income countries is needed to understand the impact of C19ST in more detail
Verbatim transcription of qualitative data is a cornerstone of analytic quality and rigor, yet the time and energy required for such transcription can drain resources, delay analysis and hinder the timely dissemination of qualitative insights. In recent years, software programs have presented a promising mechanism to accelerate transcription, but the broad application of such programs has been constrained due to expensive licensing or per-minute fees, data protection concerns, and limited availability of such programs in many languages. In this article, we outline our process of developing and adapting a free, open-source, speech-to-text algorithm (Whisper by OpenAI) into a usable and accessible tool for qualitative transcription. Our program, which we have dubbed Vink for voice to ink, is available under a permissive open-source license (and thus free of cost). We assessed Vinks reliability in transcribing authentic interview audio data in 14 languages, and identified high accuracy and limited correction times in most languages. A majority (9 out of 12) of reviewers evaluated the software performance positively, and all reviewers whose transcript had a word-error-rate below 20% (n=9) indicated that they were likely or very likely to use the tool in their future research. Our usability assessment indicates that Vink is easy-to-use, and we are continuing further refinements based on reviewer feedback to increase user-friendliness. With Vink, we hope to contribute to facilitating rigorous qualitative research processes globally by reducing time and costs associated with transcription, and expanding the availability of this transcription software into several global languages. With Vink running on the researchers computers, data privacy issues arising within many other solutions do not apply.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.